CN Stock MarketDetailed Quotes

Qingdao Vland Biotech INC. (603739)

Watchlist
  • 15.61
  • -0.29-1.82%
Market Closed Jan 16 15:00 CST
3.95BMarket Cap47.30P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Qingdao Vland Biotech INC. (603739) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Enzyme preparation238.88M36.63%
Animal health products147.37M22.60%
Other141.86M21.75%
Microecology112.6M17.27%
Other business11.48M1.76%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Food manufacturing industry945.43M71.58%
Pharmaceutical manufacturing industry336.36M25.47%
Other business38.97M2.95%

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
Domestic582.83M89.36%
Abroad57.88M8.88%
Other business11.48M1.76%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -